Podcasts about stroke ninds

Welcome to season 6 of Hope for the Agora Podcast.Karen Kleine Deters shares her story of journeying with FND -- Functional Neurologic Disorder.Functional neurologic disorder (FND) refers to a neurological condition caused by changes in how brain networks work, rather than changes in the structure of the brain itself, as seen in many other neurological disorders. Physical symptoms of FND are genuine but cannot be explained by changes in the brain structure. The exact cause of FND is unknown.Resources:National Institute of Neurological Disorders and Stroke (NINDS). Functional Neurological Disorder Information Page. https://www.ninds.nih.gov/health-information/disorders/functional-neurological-disorderStone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms and signs in neurology: assessment and diagnosis. *Journal of Neurology, Neurosurgery & Psychiatry, 76*(Suppl I), i2–i12. https://jnnp.bmj.com/content/76/suppl_1/i2Support & Awareness OrganizationsFND Hope International – https://fndhope.orgThe Functional Neurological Disorder Society (FNDS) – https://www.fndsociety.orgMayo Clinic: Functional Neurological Disorder – https://www.mayoclinic.org/diseases-conditions/conversion-disorder/symptoms-causes/syc-20355197Podscasts and storiesNeurology Podcast by the American Academy of Neurology (AAN) – https://www.aan.com/podcastFND Portal Podcast (FND Hope International) – https://fndhope.org/fnd-portal-podcast

The brain is the most complex part of the human body, controlling thought, memory, emotion, motor skills, sensory input and all the processes that regulate our bodies. How exactly does it work, and how are clinicians able to determine whether brain changes are a result of normal aging, Alzheimer's disease, or something else? Dr. Victoria Williams joins the podcast to explain important concepts in neuropsychology, from the difference between cognition and intelligence to how memories are made, and discuss how cognitive tests work in memory clinics. Guest: Victoria Williams, PhD, neuropsychologist, UW Health, assistant professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health Show Notes Are you a clinician interested in receiving continuing education (CE) credits for listening to this episode? Find credit designation information, disclosures and evaluation information on our website and on the UW–Madison Interprofessional Continuing Education Partnership (ICEP) website. The accreditation for this course expires 3/25/2025. After this date, you will no longer be able to access the course or claim credit. Learn more about the domains and structure of the brain through the National Institute of Neurological Disorders and Stroke (NINDS) website. Learn more about Dr. Williams at her bio on the University of Wisconsin Department of Medicine website. Connect with Us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.

In the exhilarating realm of fitness, where iron clangs and determination resonates, the gym becomes a sanctuary for self-improvement. However, amidst the pursuit of sculpted physiques and increased endurance, many find themselves encountering an unexpected adversary: back pain. Picture this – you're pushing your limits, eager to surpass personal records, but suddenly, a sharp twinge in your lower back brings everything to a halt. What causes this unwelcome interruption in our fitness journey, and how can we steer clear of it? Understanding the Causes: Statistics reveal that a staggering 80% of individuals will experience back pain at some point in their lives, and gym enthusiasts are no exception. While the gym is a hotspot for physical transformation, certain practices may inadvertently contribute to back pain. Poor form, overtraining, and neglecting warm-up routines are common culprits. According to reputable sources like the American Council on Exercise (ACE) and the National Institute of Neurological Disorders and Stroke (NINDS), these factors can lead to strains, sprains, and even more severe injuries. Empowering Gym Goers: Rather than dwelling on what to avoid, let's shift our focus to empowering gym-goers with knowledge that fosters injury prevention. Proper warm-ups, stretching, and maintaining good posture during exercises can significantly reduce the risk of back pain. Certified fitness trainers and chiropractors play a crucial role in guiding individuals toward safer workout practices. Chiropractors, specifically trained in musculoskeletal health, can offer personalized advice and adjustments to enhance biomechanics, ensuring a safer and more effective fitness journey. Chiropractic Support for Fitness Goals: Chiropractors are not just healers but proactive partners in your fitness journey. Regular chiropractic care can enhance joint mobility, correct imbalances, and improve overall spinal health. By addressing misalignments and providing tailored exercise recommendations, chiropractors become allies in preventing back pain and optimizing performance. Incorporating chiropractic sessions into your routine can be a game-changer, offering a holistic approach to wellness that complements your fitness goals. Conclusion: As we navigate the labyrinth of gym-induced back pain, the key lies in arming ourselves with knowledge and proactive habits. Instead of fixating on restrictions, let's celebrate the limitless possibilities of a pain-free fitness journey. Remember, every ache is a signal; our bodies are communicative guides that deserve attention and care. So, will you continue to approach the gym with blind determination, or will you embark on a journey of mindful strength-building, guided by the wisdom of your body? Legal Disclaimer: The information provided in this article is for informational purposes only and should not be considered as medical advice. Readers are encouraged to seek the advice of healthcare professionals, including chiropractors, for personalized guidance based on their individual health needs. --- Send in a voice message: https://podcasters.spotify.com/pod/show/trishulvadi/message

Epstein-Barr virus is one of the nine known herpesviruses and one of the most common viruses found in humans. It is estimated that approximately 90% of the world´s population is infected with EBV. Infections typically occur in early childhood and are usually asymptomatic. However, when infections occur later in life, they frequently cause infectious mononucleosis (“glandular fever”) and other serious complications. The virus is also associated with certain cancers – approximately 200,000 cancer cases worldwide, including several types of lymphoma, are attributed to EBV. To explore whether there is a link between MS and EBV, a team of researchers studied more than 10 million active duty US military personnel between 1993 and 2013. Dr. Alberto Ascherio from the Harvard T.H. Chan School of Public Health led the study. NIH's National Institute of Neurological Disorders and Stroke (NINDS) partly supported the work. The results appeared in Science on January 13, 2022. The results documented that EBV infection is by far the most important risk factor for multiple sclerosis.

grantsinfo@nih.gov. Agency Name:National Institutes of HealthDescription:(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application.Link to Additional Information:http://grants.nih.gov/grants/guide/pa-files/PAR-21-267.htmlGrantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: NIH OER Webmaster grantsinfo@nih.gov If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster --- Support this podcast: https://podcasters.spotify.com/pod/show/blackownedblackgrown/support

Though brain and cognitive changes are typically diagnosed as one form of dementia, recent studies have shown that mixed dementia is more common than previously thought. Mixed dementia, also known as Multiple-etiology dementia, is a condition where brain changes are caused by more than one neurological disease, such as Alzheimer's disease, Lewy body dementia (LBD), or frontotemporal dementia. Dr. Roderick Corriveau joins the podcast to discuss what is known about mixed dementia and how the field of studying neurological diseases is advancing to diagnose and treat this condition. Guest: Roderick Corriveau, PhD, program director, National Institute of Neurological Disorders and Stroke (NINDS), NIH Lead, Alzheimer's Disease-Related Dementias (ADRD) Summits Show Notes Read more about the National Institutes of Neurological Disorders and Stroke (NINDS) campaign, “Mind Your Risks,” at the Mind Your Risks website. Learn more about mixed dementia on the Alzheimer's Association website. Learn more about Dr. Corriveau at his bio on the National Institutes of Neurological Disorders and Stroke website. Learn more about NINDS on their website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter.

Emyria Ltd (ASX:EMD) Michael Winlo tells Proactive the company has been accepted into the US National Institute of Health's (NIH) Preclinical Screening Platform for Pain program. The NIH's National Institute of Neurological Disorders and Stroke (NINDS) — also the leading funder of neurological research in the US — will run the study as part of a broader initiative to stem the opioid public health crisis. #ProactiveInvestors #Emyria #asx #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

In the fiscal year 2021, the National Institute of Health (NIH) funded only 16,959 out of 80,878 research project grants.  In other words, the success rate was 21%. And the total funding amount was $8,827,444,624. The question I had was, “What does it take to get grant approval and launch an NIH funded research project?” To answer this question, I invited Dr. Manish Shah,  Professor of Pediatrics at Baylor College of Medicine and Attending Physician in the Texas Children's Hospital Emergency Center in Houston.  Dr. Shah has served on several national committees to advocate for improvements in pediatric and prehospital emergency care.  His research has focused on developing, implementing, and studying outcomes related to evidence-based protocols for various clinical conditions, including seizures.  Dr. Shah is currently the Principal Investigator for the Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study, which has been funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is being conducted in the Pediatric Emergency Care Applied Research Network (PECARN). Please join me in welcoming Dr. Shah on the Clinical Trial Podcast.  This episode is brought you by Florence Healthcare. To learn more, please visit https://florencehc.com/

The number of Americans living with Alzheimer's Disease (AD) continues to grow at an exponential rate. Currently, more than 6 million Americans have AD, and that number is expected to double by 2050. But recent research findings are beginning to show the important role diagnostics may play in the next era of AD. New diagnostic innovations could unleash a future of effective therapies, treatments, and improved outcomes for patients who suffer from this disease. In this episode, host Dr Pat Alagia, senior medical director for Women's and Reproductive Health at Quest Diagnostics, welcomes Dr Michael K. Racke to discuss: The current tools and methods available to physicians when diagnosing AD The important role of blood-based biomarkers in AD and the high impact this new testing solution can have on early diagnosis, as well as management of the disease Encouraging new treatments and diagnostic pathways for AD aiming to slow disease progression and improve quality of life Multilayered interventions to help prevent or delay risk of AD including a healthy diet, exercise, and cognitive stimulation   About our guests Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. He is a leader in the field of neurology and neuroimmunology with special expertise in multiple sclerosis.   After receiving his Doctor of Medicine from the University of Medicine and Dentistry of New Jersey, Dr Racke completed a medical internship and neurology residency at Emory University School of Medicine, followed by a neuroimmunology fellowship at the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH).   Dr Racke's research focuses on developing novel tests for neurologic disorders, including monitoring therapeutic responses in diseases such as multiple sclerosis. He has authored more than 200 peer-reviewed papers, book chapters, and reviews on the pathogenesis of neuroimmunology diseases. He has over 3 decades of leadership experience in academia and clinical practice and continues to serve on several national professional society committees.    Dr Racke is board certified by the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology and American Association of Immunologists.   ------------------------------ Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. More information is available at www.QuestDiagnostics.com

Dr. Gregg Day talks with Dr. Avi Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS), about COVID brain fog and other cognitive syndromes. Read the full article referenced in this podcast in the Washington Post.

The topic of this episode is “Role of EEG in Pediatric Emergency Department” To explore this topic further, I invited Dr. Manish Shah Professor of Pediatrics at Baylor College of Medicine and Attending Physician in the Texas Children's Hospital Emergency Center in Houston.  Dr. Shah is passionate about improving pediatric prehospital and hospital-based emergency care on local, statewide and national levels through advocacy, education, and research. As a former appointed member of the U.S. Department of Transportation's National Emergency Medical Services Advisory Committee (NEMSAC) from 2015-2017 and a past chair of the Emergency Medical Services (EMS) subcommittee for the American Academy of Pediatrics Section of Emergency Medicine from 2011-2014, he has collaborated with stakeholders to enhance awareness of issues of national significance in pediatric prehospital care.  He has collaborated with colleagues across the United States to develop an online EMS educational resource for physicians, co-create the curriculum and educational research for the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program at Texas Children's Hospital, and develop an EMS training curriculum for the Botswana Ministry of Health.  In addition, Dr. Shah has lectured at the National Association of EMS Physicians (NAEMSP) and Emergency Medical Services for Children (EMSC) Annual Meetings to promote understanding of the special needs of children in the prehospital environment. Dr. Shah is currently the Principal Investigator for the Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study, which has been funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is being conducted in the Pediatric Emergency Care Applied Research Network (PECARN). This podcast is brought to you by Ceribell Inc. To learn more, visit ceribell.com  

Shazia Ahmad, Senior Director, Head of Patient & Physician Services at UBC, earned a B.S. in physiology and neurobiology from the University of Maryland and has 20+ years of experience in the therapeutic development industry. Shazia is a seasoned thought leader in the rare disease space with a passion for ensuring the patient journey and diagnostic experience is implemented in every program she develops. Shazia has also served as a study coordinator at the National Institutes of Health (NIH). While at the NIH, Shazia coordinated intramural clinical trials across the various institutes, including the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI). Shazia is a thought-leader in patient advocacy, with a desire to improve healthcare and integrate successful solutions that bring optimal access and diversity to clinical trials. Shazia serves as a Board Advisor on the HPV Alliance, a non-profit organization that helps to advance the prevention of HPV-related cancers through education, advocacy and research. Her passion for the diverse people of the rare disease community continues to drive her work though the implementation of patient advocacy initiatives. Connect with her on LinkedIn: https://www.linkedin.com/in/shaziakahmad/ Follow her on Twitter at: @ShaziaKAhmad

Is there life beyond academia for pain researchers? That question is the focus of PRF's latest podcast – and the answer is a resounding “yes”! This optimistic outlook comes from four podcast participants who all successfully made the transition from studying pain in the ivory tower to alternative careers, including: --Alexandria Magnusdottir, PhD, Trainee Solicitor in Patent Litigation, Bristows, UK --Steve Medhurst, PhD, UK Head of Field Medical Excellence, Novartis UK --Candler Paige, PhD, Chief Executive Officer, Doloromics, US --Alex Tuttle, PhD, Chief of Staff (Acting), National Institute of Neurological Disorders and Stroke (NINDS), US The group spoke with PRF Correspondent Larissa de Clauser, a postdoctoral fellow at Eurac, Bolzano, Italy, to discuss their transitions from academia into non-academic roles, sharing their motivations, struggles, day-to-day work responsibilities, and advice to make such transitions as smooth as possible.

Around the world, COVID-19 has been awful. Many, likely millions of people, who have survived their COVID-battle, face a difficult array of symptoms. Breathing problems, joint pain, heart palpitations, brain fog are a few of them. This is part 2 of a three-part podcast series on long-COVID. This episode focuses on brain fog, one of the difficult symptoms of long-COVID. It's a conversation with neuroimmunologist Dr. Avi Nath, who is intramural clinical director of the National Institute for Neurological Disorders and Stroke (NINDS) at the US National Institutes of Health (NIH). There is a story in Nature Methods to go along with this podcast about long-COVID.

Show NotesFebruary 17, 2021IntroductionMany thanks to Jennifer Frontera, MD, Professor of Neurology at NYU Grossman School of Medicine, New York, New York, for discussing the new Neuro Databank-Biobank for COVID-19. Dr. Frontera is a neurocritical care specialist and has been caring for COVID-19 patients in New York City since the start of the pandemic. She has contributed to several important research publications on this topic found at www.pubmed.gov.“Disaster Medicine” in NYCDr. Frontera described the challenges of practicing “disaster medicine” at the onset of the pandemic. The high numbers of COVID-19 infected patients required impromptu field hospitals and the recruitment of all available medically trained personnel. New York City physicians are now applying lessons learned to the current “second surge” of the disease.Neuro Databank-BiobankTo better understand the neurologic complications of COVID-19, NYU collected information on approximately 5,000 patients last spring. With the help of a grant from the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke (NINDS), the program now accepts data and specimens from physicians treating COVID-19-infected patients anywhere in the country. The registry also welcomes information and samples from outpatients with “Long-COVID.” Reimbursement is available to compensate for the time required to complete the data entry form.Dr. Frontera encouraged both academic and community neurologists to contact the databank to submit their experience with COVID-19 patients. https://med.nyu.edu/departments-institutes/population-health/divisions-sections-centers/biostatistics/research/nih-neurodatabank-neurobiobankConclusionsAs much as the Neuro Databank and Biobank welcomes COVID-19 samples, Dr. Frontera and I agree that vaccination is a low-risk and highly effective way to prevent the disease and the neurologic complications that may result. The registry will gladly settle for fewer contributions if it means a healthier population!

The Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program aims to inform and empower neuroscientists at all career stages to enhance the rigor and reproducibility of their research. Begin this series with Oswald Steward and Lique Coolen as they cover the genesis of the FRN program, the objectives of the podcast series, and the resources that you can access to enhance rigorous research practices in neuroscience. Pathways to Enhance Rigor: A Collection of Conversations is a part of the Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program. This program is supported by the National Institute for Neurological Disorders and Stroke (NINDS), grant number 5R25NS112922-02. The FRN program is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

Although there are many hurdles to enhancing rigor in neuroscience, one fact is clear: implementing rigorous research practices today will enhance the credibility of the field tomorrow. Wrap up this series with Emily Sena, Eric Nestler, and Walter Koroshetz as they discuss the rewards to conducting rigorous research, how institutions, journals, and funders can step up to enhance rigor across the field, and ways for individuals to shift the needle in tackling this collective challenge. Pathways to Enhance Rigor: A Collection of Conversations is a part of the Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program. This program is supported by the National Institute for Neurological Disorders and Stroke (NINDS), grant number 5R25NS112922-02. The FRN program is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

How can researchers shape modern scientific culture to incentivize more sustainable, rigorous science? Hear from Michael Lehman, Ghazaleh Sadri-Vakili, and Tanita Casci as they cover the critical importance of incentivizing rigorous research today, as well as ways you can advance rigorous research practices at any level in your career to invigorate the field. Pathways to Enhance Rigor: A Collection of Conversations is a part of the Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program. This program is supported by the National Institute for Neurological Disorders and Stroke (NINDS), grant number 5R25NS112922-02. The FRN program is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

Join neuroscientists Letisha Wyatt, Jane Roskams, and Maryann Martone as they delve into the challenges neuroscience has faced regarding data storage, management, and sharing. They discuss the historical transition from analog to digital data, the complexities of neuroscience data, and paths forward to foster more sound data stewardship for the larger scientific community. Pathways to Enhance Rigor: A Collection of Conversations is a part of the Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program. This program is supported by the National Institute for Neurological Disorders and Stroke (NINDS), grant number 5R25NS112922-02. The FRN program is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

When developing a study, there are many sources of biases that can affect experimentation or interpretation of results. Join Christie Fowler, Olavo Amaral, and Kip Ludwig as they discuss the various considerations neuroscientists must face to conduct research while minimizing bias and maximizing objectivity. Pathways to Enhance Rigor: A Collection of Conversations is a part of the Society for Neuroscience’s (SfN’s) Foundations of Rigorous Neuroscience Research (FRN) program. This program is supported by the National Institute for Neurological Disorders and Stroke (NINDS), grant number 5R25NS112922-02. The FRN program is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

“Pathways to Enhance Rigor: A Collection of Conversations” is a limited-series podcast featuring neuroscientists discussing ways to better embed rigor into every part of the scientific process, from experimental design to sharing with the public. These conversations highlight the past, present, and future of rigor in neuroscience and emphasize how individuals can contribute to creating a culture of rigor in their lab and beyond. This podcast is a part of the Society for Neuroscience’s Foundations of Rigorous Neuroscience Research (FRN) program. Supported by the National Institute for Neurological Disorders and Stroke (NINDS), FRN is designed to inform and empower neuroscientists at all career levels to enhance the rigor in their research and the scientific culture at large.

In Episode 25, we hear from Dr. Ramon R. Diaz-Arrastia, Professor of Neurology at the University of Pennsylvania. He discusses biological research regarding brain injury. Dr. Diaz-Arrastia also tells us about research projects that are currently being worked on, as well as what we can look forward to in the future. Dr. Diaz-Arrastia is Professor of Neurology at the University of Pennsylvania, where he leads the Traumatic Brain Injury Clinical Research Initiative. Dr. Diaz-Arrastia received his MD and PhD degrees from Baylor College of Medicine, and completed post-graduate training at Harvard and Columbia. Prior to coming to Penn, he served on the faculty at the University of Texas Southwestern, the Uniformed Services University of the Health Sciences, and the National Institute of Neurologic Disorders and Stroke (NINDS). Dr. Diaz-Arrastia has published over 200 primary research papers, as well as over 40 invited reviews and book chapters. He has also served in several national committees related to traumatic brain injury, epilepsy, and dementia, convened by the Institute of Medicine, the National Institutes of Health, the Department of Defense, and the Veterans Administration. He was a member of the Institute of Medicine Committee on the Public Health Dimensions of the Epilepsies.

Dr. Shai Silberberg is the Director of Research Quality at the NIH National Institute of Neurological Disorders and Stroke (NINDS) leading the Institute efforts to increase the excellence of science and the completeness of research reporting. Prior to joining NINDS, Dr. Silberberg was an Associate Professor at Ben-Gurion University of the Negev in Israel, investigating the biophysical functions and physiological roles of ion channels.